BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23839008)

  • 1. Repeated bland-TAE using small microspheres injected via an implantable port-catheter system for liver metastases: an initial experience.
    Tanaka T; Nishiofuku H; Maeda S; Masada T; Anai H; Sakaguchi H; Kichikawa K
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):493-7. PubMed ID: 23839008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres.
    Osuga K; Hori S; Hiraishi K; Sugiura T; Hata Y; Higashihara H; Maeda N; Tomoda K; Nakamura H
    Cardiovasc Intervent Radiol; 2008; 31(6):1108-16. PubMed ID: 18543028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superselective particle embolization enhances efficacy of radiofrequency ablation: effects of particle size and sequence of action.
    Tanaka T; Isfort P; Braunschweig T; Westphal S; Woitok A; Penzkofer T; Bruners P; Kichikawa K; Schmitz-Rode T; Mahnken AH
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):773-82. PubMed ID: 23070107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An assessment of therapeutic effects by transcatheter arterial embolization (TAE) with degradable starch microspheres (DSM) for hepatic malignant tumors].
    Hirai K; Yamashita K; Aoki Y; Sakai T; Abe M; Tanikawa K; Noguchi H; Miyazono K; Kubo Y; Saitsu H
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):772-80. PubMed ID: 2550567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session.
    Bonomo G; Della Vigna P; Monfardini L; Orgera G; Chiappa A; Bianchi PP; Zampino MG; Orsi F
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1372-9. PubMed ID: 22271077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial port systems for treatment of liver metastases: factors affecting patency and adverse events.
    Ricke J; Hildebrandt B; Miersch A; Nicolaou A; Warschewske G; Teichgräber U; Lopez Hänninen E; Riess H; Felix R
    J Vasc Interv Radiol; 2004 Aug; 15(8):825-33. PubMed ID: 15297586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An initial clinical study on the efficacy of cisplatin-releasing gelatin microspheres for metastatic liver tumors.
    Nitta N; Ohta S; Tanaka T; Takazakura R; Toyama T; Sonoda A; Seko A; Furukawa A; Takahashi M; Murata K; Kurumi Y; Tani T; Sakamoto T; Tabata Y
    Eur J Radiol; 2009 Sep; 71(3):519-26. PubMed ID: 18617345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of therapeutic effects by transcatheter arterial embolization (TAE) in hepatic malignant tumors with degradable starch microspheres (DSM)].
    Hirai K; Yamashita K; Aoki Y; Fujimoto T; Tanaka M; Sakai T; Majima Y; Noguchi H; Miyazone K; Kubo Y
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2653-8. PubMed ID: 2843132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An early-stage, non-hypervascular HCC successfully treated by superselective, bland transarterial embolization using 40-μm microspheres.
    Tanaka T; Maeda S; Nishiofuku H; Masada T; Sato T; Anai H; Sakaguchi H; Kichikawa K
    Anticancer Res; 2014 Apr; 34(4):1947-51. PubMed ID: 24692730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transcatheter arterial chemoembolization and selective hepatic arterial infusion using totally implantable reservoir].
    Sakurai Y; Kodaira S; Teramoto T; Miyajima N; Kuzuoka M; Ishii T; Arisawa Y; Takabayashi T; Abe O
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2473-8. PubMed ID: 3415258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
    Rand T; Loewe C; Schoder M; Schmook MT; Peck-Radosavljevic M; Kettenbach J; Wolf F; Schneider B; Lammer J
    Cardiovasc Intervent Radiol; 2005; 28(3):313-8. PubMed ID: 15886943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant islet cell tumor of the pancreas with multiple liver metastases effectively treated by transcatheter arterial embolization with degradable starch microspheres--a case report].
    Takahashi H; Tono T; Matsushita M; Yasue A; Okada K; Hata T; Kano T; Iwazawa T; Matsui S; Nakano Y; Yano H; Kinuta M; Okamura J; Monden T
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1936-9. PubMed ID: 11086449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
    Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
    J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes.
    Zener R; Yoon H; Ziv E; Covey A; Brown KT; Sofocleous CT; Thornton RH; Boas FE
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):569-576. PubMed ID: 30627774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemo-embolization therapy of unresectable liver metastases using implantable infusion port].
    Minami T; Awane Y
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2875-9. PubMed ID: 2551230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemoembolization with degradable starch microspheres for liver metastases of colorectal cancer].
    Kondo M; Itani K; Yoshikawa T; Oyamada H; Ichikawa H; Kokura S; Tainaka K; Sugino S
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):535-40. PubMed ID: 1901474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of liver metastasis of leiomyosarcoma of residual stomach successfully treated by TAE and intra-hepato-arterial chemotherapy with infusion-a-port with administration of epirubicin].
    Matsuura K; Uraguchi T; Kobayashi Y; Ichikawa T; Tanaka O; Nagai J; Shinohara K; Shimanuki K; Touru M; Miyata M
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2671-4. PubMed ID: 7979432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
    Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemoembolization with degradable starch microspheres for liver metastases in colorectal cancer].
    Itani K; Yoshikawa T; Oyamada H; Takano H; Ichikawa H; Tainaka K; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2897-900. PubMed ID: 2506828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Safety and Efficacy of Different Models of Target Vessel Regional Chemotherapy for Gastric Cancer with Liver Metastases.
    Chen H; Gao S; Yang XZ; Chen LJ; Liu P; Xu HF
    Chemotherapy; 2016; 61(2):99-107. PubMed ID: 26618449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.